IndraLab

Statements

JOSD2 activates Carcinoma, Non-Small-Cell Lung. 1 / 1

| 1

reach

"JOSD2 has been shown to promote non-small cell lung cancer (NSCLC) cell proliferation by stabilizing metabolic enzymes aldolase A and phosphofructokinase-1, suggesting that JOSD2 is a positive regulator of glucose metabolism [4]."

35836282

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

JOSD2 activates Carcinoma, Non-Small-Cell Lung. 1 / 1

INDRA sources:

Databases

Reading